SCHEMBL3171391

SCHEMBL3171391

OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.OP(O)O.[NaH].[NaH].[NaH].[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL176345 1.00
SCHEMBL2023779 1.00
SCHEMBL77573 1.00
SCHEMBL27473407 1.00
SCHEMBL10681699 0.91
Water SCHEMBL3949364 0.91
SCHEMBL29138095 0.91
Water SCHEMBL15124695 0.91
Phosphine SCHEMBL12005224 0.91
SCHEMBL18245691 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022467-A1 ANTI-CANCER PHOSPHONATE ANALOGS BOOJAMRA CONSTANTINE G 2010-01-28 US disclosed
US-7452901-B2 Anti-cancer phosphonate analogs GILEAD SCIENCES, INC. (US) 2008-11-18 US disclosed
US-20060079478-A1 Anti-cancer phosphonate analogs GILEAD SCIENCES, INC. 2006-04-13 US disclosed
EP-1617848-A2 ANTI-CANCER PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2006-01-25 EP disclosed
WO-2004096235-A2 ANTI-CANCER PHOSPHONATE ANALOGS GILEAD SCIENCES, INC. (US) 2004-11-11 WO disclosed